PENGARUH PEMBERIAN TERAPI OKSIGEN HIPERBARIK 2,4 ATA TERHADAP KADAR C-REACTIVE PROTEIN (CRP) DARAH MENCIT MODEL RHEUMATOID ARTHRITIS
DOI:
https://doi.org/10.30649/obj.v2i2.33Keywords:
rheumatoid arthritis, oxygen hyperbaric therapy, C-Reactive ProteinAbstract
Background: Rheumatoid Arthritis (RA) is an autoimmune disease with an increasing
prevalence from year to year. RA mortality continues to increase in the last 1 decade due to
the absence of effective prevention and therapy. Hyperbaric oxygen therapy can be an
adjuvant therapy for Rheumathoid Arthritis.
Objective: This study uses Hyperbaric Oxygen Therapy to reduce the inflammatory reaction
in patients with Rheumatoid Arthritis.
Method: Samples used are 16 male balb/c mice, divided into 2 groups, 1) group of induced
experimental animals as models of Rheumatoid Arthritis 2) group of induced experimental
animals as models of Rheumatoid Arthritis and given 3x30 minutes of 2.4 ATA hyperbaric
oxygen therapy for 10 consecutive days. On 59th day, ELISA screening test is performed for
C-ReactiveProtein measurement.
Result: The average results of C-Reactive Protein levels between 2 groups, are, the group of
mice with rheumatoid arthritis model that was not treated with HBO therapy had an average
CRP level of 0.204 Pg / ml, while the group of mice with rheumatoid arthritis model which is
treated with HBO therapy has a mean CRP level of 0.113 Pg / ml.
Conclusion: There is an effect of hyperbaric oxygen therapy to C-Reactive Protein level in
mice with rheumatoid arthritis model.
References
Andisari, H.E., 2018. Recent Therapeutics Policies of Arthritis Rheumatoid (part I). Oceana
Biomedicina Journal, 1(1), pp.12-24.
Gibofsky, A. (2014) ‘Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis:
A Synopsis’, Am. J. Manag. Care, 20(7 Suppl), pp. S128----35.
van den Hoek, J. et al. (2017) ‘Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study’, Rheumatology International. Springer Berlin Heidelberg,
(4), pp. 487–493. doi: 10.1007/s00296-016-3638-5.
Karadurmus, N. (2010) ‘Potential benefits of hyperbaric oxygen therapy on atherosclerosis
and glycaemic control in patients with diabetic foot Korzystny wpływ leczenia tlenem
w komorze hiperbarycznej na czynniki ryzyka miażdżycy i kontrolę glikemii u
chorych z zespołem stopy cu’, 61(3), pp. 275–279.
Ledingham, J., Snowden, N. and Ide, Z. (2017) ‘Diagnosis and early management of
inflammatory arthritis’, Bmj, p. j3248. doi: 10.1136/bmj.j3248.
Li, N. et al. (2017) ‘Wound healing process and related laboratory indexes in patients with
type 2 diabetes mellitus after hyperbaric oxygen intervention .’, 28(20), pp. 9005–
Nainggolan, E. (Puslitbang B. dan F. B. P. dan P. K. and Kesehatan, D. K. R. (2009)
Prevalensi dan Determinan Penyakit Rematik di Indonesia, Majalah Kedokteran
Indonesia.
Van Neck, J. W. et al. (2017) ‘Hyperbaric oxygen therapy for wound healing in diabetic rats:
Varying efficacy after a clinically-based protocol’, PLoS ONE, 12(5), pp. 1–16. doi:
1371/journal.pone.0177766.
Novak, S. et al. (2016) ‘Anti-Inflammatory Effects of Hyperbaric Oxygenation during DSSInduced Colitis in BALB / c Mice Include Changes in Gene Expression of HIF-1 ,
Proinflammatory Cytokines , and Antioxidative Enzymes’, 2016. doi:
1155/2016/7141430.
Rajnics, P. et al. (2017) ‘iMedPub Journals The Hematologic Toxicity of Methotrexate in
Patients with Autoimmune Disorders Keywords : Case Reports Patient ’ s
characteristics’, pp. 1–6.
Thom, S. R. (2009) ‘Oxidative stress is fundamental to hyperbaric oxygen therapy’, pp. 988–
doi: 10.1152/japplphysiol.91004.2008.
Widdifield, J. et al. (2018) ‘Causes of death in rheumatoid arthritis: How do they compare to
the general population?’, Arthritis Care & Research, pp. 0–2. doi: 10.1002/acr.23548.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Oceana Biomedicina Journal

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.